Hepatitis B vaccine in celiac disease: Yesterday, today and tomorrow

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

632

HTML

4334

Tables (1-1)

111

Sum=5077

Feb 14, 2013 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 14, 2013; 19(6): 838-845
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.838

Table 1 People who have anti-HBs titre after completion of primary vaccine series less than 10 mIU/mL

	Celiac patients(no responders, %)	Control subjects(no responders, %)
Leonardi et al[30]	30/60 (50)	7/60 (11.7)
Ahishali et al[42]	8/25 (32)	0/20 (0)
Zingone et al[43]	31/51 (60.7)	13/48 (27.08)
Ertekin et al[44]	20/52 (38.5)	2/20 (10)
Noh et al[56]	13/19 (68.4)	-

Citation: Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: Yesterday, today and tomorrow. World J Gastroenterol 2013; 19(6): 838-845
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/838.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i6.838